🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,067 results for “Hospital” Clear

  1. Keverprazan

    The First People's Hospital of Lianyungang

    H. Pylori Infection

    approved small molecule active

    1 trial

  2. LABA/LAMA or Placebo inhalation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchiectasis Adult

    approved small molecule active

    1 trial

  3. LCS® Complete™ Mobile Bearing Knee Systems

    International Peace Maternity and Child Health Hospital

    Knee Osteoarthritis

    approved other completed

    1 trial

  4. LNG-IUS

    Hospital Authority, Hong Kong

    Endometriosis

    approved small molecule completed

    1 trial

  5. Lecanemab 10 mg/kg

    The First People's Hospital of Lianyungang

    Alzheimer s Disease

    approved small molecule active

    1 trial

  6. Ledipasvir 90mg/Sofosbuvir 400 mg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule terminated

    1 trial

  7. Levocarnitine Injection

    The First People's Hospital of Lianyungang

    Renal Dialysis

    approved small molecule completed

    1 trial

  8. Levofloxacin

    Hospital Authority, Hong Kong

    Urinary Tract Infection

    approved small molecule active

    1 trial

  9. Levothyroxine

    The First People's Hospital of Lianyungang

    Heart Failure

    approved small molecule active

    1 trial

  10. Lithium Carbonate 250 MG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sleep Deprivation

    approved small molecule completed

    1 trial

  11. Live Combined Bifidobacterium and Lactobacillus

    The First People's Hospital of Lianyungang

    Functional Constipation

    approved small molecule active

    1 trial

  12. Longidaza

    The First People's Hospital of Lianyungang

    Bacterial Vaginosis

    approved small molecule active

    1 trial

  13. Low dose Oliceridine

    The First People's Hospital of Lianyungang

    Oliceridine

    approved small molecule active

    1 trial

  14. Low-Molecular-Weight Heparins Calcium Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pneumonia

    approved small molecule completed

    1 trial

  15. Lucentis

    Hospital Authority, Hong Kong

    Wet Macular Degeneration

    approved small molecule completed

    1 trial

  16. Lutrate Depot Trimestral 22,5 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 150 mg film-coated tablets, Femara 2.5 mg Tablets, Arimidex® 1 mg film-coated tablets, Zoladex 10,8 mg implantat, Aromasil 25 mg comprimidos recubiertos, Verzenios 100 mg film-coated tablets, Zoladex 3,6 mg implantat, Kisqali 200 mg film-coated tablets, Lutrate Depot Mensual 3,75 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 50 mg film-coated tablets

    Ningbo Cancer Hospital

    Early Breast Cancer

    approved small molecule active

    1 trial

  17. MIYAIRI 588

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depression Mild

    approved small molecule completed

    1 trial

  18. Maggot debridement therapy

    The First People's Hospital of Lianyungang

    Diabetic Foot Ulcers

    approved other active

    1 trial

  19. Measles-Rubella combined vaccine(MR)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Measles

    approved mab completed

    1 trial

  20. Mecobalamin

    Sichuan Provincial People's Hospital

    Sepsis

    approved small molecule active

    1 trial

  21. Mesalazine

    The First People's Hospital of Lianyungang

    Ulcerative Colitis, Unspecified

    approved small molecule active

    1 trial

  22. Metformin

    Xijing Hospital of Digestive Diseases

    Gastric Intestinal Metaplasia

    approved small molecule completed

    1 trial

  23. Methimazole

    The First People's Hospital of Lianyungang

    Graves Disease

    approved small molecule active

    1 trial

  24. Methotrexate plus sulfasalazine

    Hospital Authority, Hong Kong

    Rheumatoid Arthritis

    approved small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources